Key facts
- Notable investors include iAccel (Seongnam-si).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for EMBST
- ·The full record, as it builds
Funding rounds
No funding rounds for EMBST are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EMBST
Developer of encapsulation technology designed to enhance mineral bioavailability and maximize efficacy in nutritional applications. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Seongnam-si, South Korea
- Founded
- 2022
- Ownership
- Privately Held (backing)
EMBST doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EMBST shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EMBST in its N-PORT filings yet. We sweep new filings monthly.